Oxford BioDynamics PLC Sustainability Reports
Oxford BioDynamics PLC develops and commercializes precision medicine tests for life-changing diseases. Its products are built on EpiSwitch, a proprietary 3D genomic biomarker platform that enables molecular screening, evaluation, and monitoring.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 2138005Y1TK258O5U928
FIGI: BBG00FB98TX6
10 reports from 2016 to 2025
